Credit risk
Bankruptcy probability (12 mo)
Credit advice
verdict per amount and termTimeline
What happened to this company, by date
fiscal year 2026 expected by 31-07-2027
2026
09-07-2026 NBB filing Annual accounts filed
fiscal year 2025 · full schema
29-05-2026 State Gazette act Open capture
Notarial deed · General meeting · Auditor waiver · Capital increase
2025
22-12-2025 State Gazette act Capital & shares
v3.2
23-10-2025 State Gazette act Capital & shares
v3.2
21-08-2025 NBB filing Annual accounts filed
fiscal year 2024 · full schema
09-07-2025 State Gazette act Director changes
v3.2
2024
26-06-2024 NBB filing Annual accounts filed
fiscal year 2023 · full schema
23-04-2024 State Gazette act Director changes
v3.2
2022
03-08-2022 State Gazette act Statutes amendment
v3.2
25-05-2022 State Gazette act Incorporation
oprichting
Financials
TurnoverNot included in this filing
EBIT marginNot included in this filing
Net result€-2.12M-97.6%
2023: €-1.12M
2024: €-1.07M
Working capital€1.76M+78.6%
2023: €1.75M
2024: €988k
Figures by fiscal year
fiscal year 2025 · full schemaSector comparison
Fiscal year 2024 · NACE 72, Scientific research and development · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 35.0% | 53.3% | |
| Net result | €-1.07M | €-19k | |
| Equity | €775k | €685k | |
| Gross operating margin | €7k | €7k | |
| Staff costs | €494k | €723k |
€-1.62M
-232.7%
23-25
€-1.12M
-
23-25
€2.67M
+20.3%
23-25
€1.75M
+126.3%
23-25
10
+40.3%
23-25
€752k
+52.3%
23-25
€-30k
+49.1%
23-25
€913k
-36.7%
23-25
€599k
-22.8%
23-25
€290k
-55.6%
23-25
3.95
+73.6%
23-25
3.95
+73.6%
23-25
65.8%
+88.1%
23-25
0.52
-72.0%
23-25
-120.9%
+12.7%
23-25
-79.5%
-64.2%
23-25
-13.42
+68.6%
23-25
Figures by fiscal year and ratios
| Fiscal year | 2025 |
|---|---|
| Deposit | full schema |
| Revenue | - |
| EBITDA | €-1.62M |
| Net profit | €-2.12M |
| Cash flow | €-1.12M |
| Staff costs | €752k |
| Income taxes | €-30k |
| Dividends | - |
| Total assets | €2.67M |
| Equity | €1.75M |
| Debt | €913k |
| of which ≤ 1y | €599k |
| of which > 1y | €290k |
| Working capital | €1.76M |
| Employees (FTE) | 10.1 |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 3.95 |
| Quick ratio | 3.95 |
| Working capital ratio | 66.2% |
| Solvency | 65.8% |
| Debt / equity | 0.52 |
| Long-term debt ratio | 0.17 |
| Interest coverage | -13.42 |
| Gross margin | - |
| Net margin | - |
| ROA | -79.5% |
| ROE | -120.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan.
See plans →
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.67M |
| Fixed assets | 21/28 | €303k |
| Intangible fixed assets | 21 | €155k |
| Tangible fixed assets | 22/27 | €149k |
| Current assets | 29/58 | €2.36M |
| Amounts receivable within one year | 40/41 | €577k |
| Cash & bank | 54/58 | €1.56M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.67M |
| Equity | 10/15 | €1.75M |
| Contributions / capital | 10/11 | €2.48M |
| Accumulated profits (losses) | 14 | €-723k |
| Amounts payable | 17/49 | €913k |
| Amounts payable after one year | 17 | €290k |
| Amounts payable within one year | 42/48 | €599k |
| Trade debts payable within one year | 44 | €460k |
| Income statement | ||
| Gross operating margin | 9900 | €-869k |
| Operating result | 9901 | €-2.62M |
| Financial income | 75 | €595k |
| Financial charges | 65 | €121k |
| Result before taxes | 9903 | €-2.15M |
| Income taxes | 67/77 | €-30k |
| Net result for the period | 9904 | €-2.12M |
| Result to be appropriated | 9905 | €-2.12M |
Signals
2 signals
Persistent losses
Two consecutive loss-making years (2023 and 2024); equity fell accordingly. May indicate structural pressure on profitability.
View the result trend Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
No strikeouts found in the KBO publications · how complete this is
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Filing history by fiscal year and how the deadline is computed
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | 09-07-2026 | 22 d early | 2026-00276862 |
| 31-12-2024 | 31-07-2025 | 21-08-2025 | 21 d late | 2025-00391424 |
| 31-12-2023 | 31-07-2024 | 26-06-2024 | 35 d early | 2024-00175580 |
Source: the National Bank's deposit records, as we have ingested them. NOTE: our copy has a gap across June to August 2026, missing roughly 220,000 deposits; for July we hold 15,605 of about 137,000 expected. A year whose deadline falls in that window shows as not confirmed, not as not filed. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Directors
9 directors
Current directors & mandates
-
JCO Consulting SRLLegal entityDirector· perm. rep.: Jean CombalbertState Gazette act 25086684 (09-07-2025)Current14-04-2025 → present
-
QBIC VENTURE PARTNERS IIIPublic limited companyDirector· perm. rep.: Sara VANDENWIJNGAERTState Gazette act 24065353 (23-04-2024)Current04-09-2023 → present
-
Current03-08-2022 → present
-
NOSHAQ PARTNERSPrivate limited companyDirector· perm. rep.: LIMBOURG Marleen JohannaState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
-
R&D CLOSEPrivate limited companyDirector· perm. rep.: CLOSE PierreState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
-
RAPINO ManagementPrivate limited companyDirector· perm. rep.: RAPINO FrancescaState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
Show 3 more sitting directors
-
Current03-08-2022 → present
-
VENTURE COACHINGPrivate limited companyDirector· perm. rep.: MATTIVI Didier Jean-Marie JosephState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
-
Current03-08-2022 → present
Structure & network
Connections & network
9 connected companiesNetwork connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Show 2 more network connections
Shared corporate director
→
Shared corporate director
→
3 further connected companies in this network. Available in Kantoor S.
See plans →
Ownership & control
5 partiesControl over this companysits on this company's board5
61 subsidiaries · 1 location
7 subsidiaries
4 subsidiaries · 2 locations
1 subsidiary
1 subsidiary
controls
THERAtRAMEBE 0786.448.581
Locations & real estate
Registered office
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Avenue de l'Hôpital 14000 LiègeEstablishment units
1 locationTHERATRAME
since 20222.350.127.579
Parcels1
Ground area1.4 ha
Buildings1
Building footprint2.3 ha
Volume (LiDAR)538,905 m³
Tallest building48.9 m · ±8 fl.
Real-estate footprint
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62826D0504/00R002 ProtectedMonument |
Wallonia | 1.4 ha | 1 · 2.3 ha | 48.9 m · 8 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Similar
Similar companies
Comparable size, same sectorBE 0210.012.621 · Gent
BE 0795.192.043 · Sint-Joost-ten-Node
BE 0728.461.387 · Charleroi
BE 0755.686.022 · Thimister-Clermont
BE 0896.230.213 · Brussel
How this selection is made
We hold annual accounts for 27 of the 423 companies in this sector. 12 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Research and development on biotechnology72101Scientific research and development72200Other research and development on natural sciences72109